SCHEMBL6412189

SCHEMBL6412189

CCCCCCC(CCCN)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.62
GRIK2 Q13002 2/20 0.62
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
CPB2 Q96IY4 5/20 0.58
CA2 P00918 2/20 0.55
MAPK1 P28482 1/20 0.55
GPR84 Q9NQS5 3/20 0.53
FFAR1 O14842 1/20 0.53
CHRM1 P11229 1/20 0.52
AKR1A1 P14550 1/20 0.52
CHRM3 P20309 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
ADRA1A P35348 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24199997 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1CPB2
Alcohol SCHEMBL31415589 0.96 GRIK1 (0.59) GRIK1GRIK2SLC1A2SLC1A1CPB2
Alcohol SCHEMBL31415577 0.96 GRIK1 (0.59) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL15209530 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL265335 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL7901772 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL7901906 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL15209173 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL15208712 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2
SCHEMBL15208444 0.96 CPB2 (0.63) GRIK1GRIK2SLC1A2SLC1A1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272783-A1 Amino acids with affinity for the alpha2delta-protein BARTA NANCY SUE 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272783-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A GRIK1 507/4885GRIK2 181/4885SLC1A2 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.